Breakthrough in Ovarian Cancer Treatment: Identification of Receptive Proteins for Targeted Therapy

Researchers have identified two key proteins on ovarian cancer cells that can be targeted with light-activated therapy, paving the way for more precise and effective treatments against this deadly disease.
Researchers at Northeastern University have uncovered two proteins that are prominently displayed on the surface of drug-resistant ovarian cancer cells. These proteins exhibit potential as targets for innovative treatment approaches involving light-activated therapies. By exposing these proteins to specific wavelengths of light in combination with photosensitive antibodies, the cancer cells become more vulnerable to chemotherapy, opening new possibilities for more effective and less invasive treatments.
This discovery was published in the journal Photochemistry and Photobiology and marks a significant advance in the fight against one of the most deadly cancer types. Traditionally, ovarian cancer is diagnosed at an advanced stage, making it challenging to treat effectively. The new findings suggest that leveraging these proteins could facilitate targeted photoimmunotherapy, which involves activating antibodies with light to damage cancer cells while sparing healthy tissue.
The research team utilized proteomics, a technique for analyzing the full complement of proteins in ovarian cancer cells, to identify these common markers across various patient samples. Unlike previous targets, which were inconsistent, these proteins were consistently present, making them reliable candidates for therapy.
Light-activated therapy not only weakens tumor cells but also triggers an inflammatory response that enhances the immune system's ability to attack remaining cancer cells. This approach could potentially reduce the dependence on traditional chemotherapy cycles, minimize treatment-related suffering, and improve quality of life for patients.
Spring emphasized the importance of precision medicine in this context, aiming to tailor treatments specifically to individual patients based on the distinct proteins expressed by their tumors. Additionally, this technique offers benefits before surgery by making tumor cells more visible and easier to remove, thereby aiding surgical success and subsequent treatment.
Overall, this breakthrough highlights the promise of integrating photomedicine with targeted therapy to combat ovarian cancer more effectively and with fewer side effects, ultimately aiming for more personalized and less burdensome treatment options.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Rethinking the Autism Spectrum: Moving Beyond Simplistic Labels
A new perspective on autism challenges traditional spectrum labels, emphasizing the diversity of traits and needs among autistic people to foster greater understanding and acceptance.
High Risk of Sudden Cardiac Death in Male Bodybuilders, Especially Competitors
A significant number of sudden cardiac deaths have been reported among male bodybuilders, especially professionals, highlighting the health risks associated with extreme training and substance use. This research urges safer practices and medical supervision to protect athletes' heart health.
Long-term Study Links Midlife Vascular Health to Future Dementia Risk
A long-term study reveals that maintaining vascular health during midlife can significantly reduce the risk of developing dementia later in life, emphasizing early intervention on risk factors like hypertension, diabetes, and smoking.
Study Finds No Significant Benefit of Left Atrial Appendage Occlusion After Valvular Surgery in Some Patients
New research shows that surgical left atrial appendage occlusion does not significantly reduce stroke or death risk in high-risk patients after valvular surgery, guiding future treatment strategies.



